Skip to content
Trial Eligibility
Menu

Variations in Ketone Metabolism

NCT05924295

This study is recruiting at 2 US sites in 2 states, according to its ClinicalTrials.gov record last updated .

Summary

This outcome of this study will elucidate how the phenotype of the individual modulates the KE metabolic effect. Most studies of KE have been in homogenous populations, usually young, male athletes. However, two striking experiments using identical, body weight adjusted KE doses in healthy and obese individuals found that BHB area under the curve (AUC) and removal was reduced by obesity and poor metabolic health. Similarly, ketone infusion experiments found that diabetes, obesity, and insulin resistance alter BHB metabolism. It is important to determine how obesity affects KE 'sensitivity' (i.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Ketosis

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
20 to 70 years
Sex
All
Healthy volunteers
Accepted
Sponsor
Ohio State University
Last updated on ClinicalTrials.gov
May 14, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

California · 1

  • The Buck Institute · Novato, CA

Ohio · 1

  • The Ohio State University · Columbus, OH

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.